Have a personal or library account? Click to login

Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets

Open Access
|Dec 2015

References

  1. 1. R . D. Deshpande, D. V. Gowda, N. Mahammed and D. N. Maramwar, Bi-layer tablets an emerging trend: a review, Int. J. Pharm. Sci. Res. 2 (2011) 2534-2544.
  2. 2. P. H. Ashok and T. A. Kumar, A novel approach of bilayer technology: a review, Int. Res. J. Pharm. 3 (2012) 44-49.
  3. 3. A . Divya, K. Kavitha, M. R. Kumar, S. Dakshayani and SD Singh Jagadeesh, Bilayer tablet technology: An overview, J. Appl. Pharm. Sci. 1 (2011) 43-47.
  4. 4. N . D. Pujara, Bilayer tablet - An emerging trend, J. Pharm. Res. Dev. 4 (2012) 102-111.
  5. 5. Experts in solid dosage discuss the formulation and manufacture of multilayer tablets. Multilayer tablets: Key challenges and trends, Pharm. Technol. 36 (2012) 22-33.
  6. 6. U. Conte and L. Maggi, Modulation of the dissolution profiles from Geomatrix(r) multi-layer matrix tablets containing drugs of different solubility, Biomaterials 17 (1996) 889-896; DOI: 10.1016/ 0142-9612(96)83284-4.10.1016/0142-9612(96)83284-4
  7. 7. A . Kulkarni and M. Bhatia, Development and evaluation of regioselective bilayer floating tablets of atenolol and lovastatin for biphasic release profile, Iran. J. Pharm. Res. 8 (2009) 15-25.
  8. 8. S. Abdul and S. S. Poddar, A flexible technology for modified release of drugs: multi layer tablets, J. Control. Release 97 (2004) 393-405; DOI: 10.1016/j.jconrel.2004.03.034.10.1016/S0168-3659(04)00186-5
  9. 9. S. B. Bagde, B. V. Bakde, M. Channawar and A. V. Chandewar, Formulation and evaluation of bilayer tablets of metoprolol succinate and ramipril, Int. J. Pharm Pharm. Sci. 3 (2011) 174-178.
  10. 10. S. Aryal and N. Skalo-Basnet, Stability of amlodipine besylate and atenolol in multi-component tablets of mon-layer and bi-layer types, Acta Pharm. 58 (2008) 299-308; DOI: 10.2478/v10007-008-0012-5.10.2478/v10007-008-0012-519103566
  11. 11. S. R. Vaithiyalingam and V. A. Sayeed, Critical factors in manufacturing multi-layer tablets - Assessing material attributes, in process controls, manufacturing process and product performance, Int. J. Pharm. 398 (2010) 9-13; DOI : 10.1016/j.ijpharm.2010.07.025.10.1016/j.ijpharm.2010.07.02520656000
  12. 12. F. Podczeck, Theoretical and experimental investigations into the delamination tendencies of bilayer tablets, Int. J. Pharm. 408 (2011) 102-112; DOI : 10.1016/j.ijpharm.2011.02.007.10.1016/j.ijpharm.2011.02.00721316433
  13. 13. F. Eisenacher, A. Schadlich and K. Mader, Monitoring of internal pH gradients within multi-layer tablets by optical methods and EPR imaging, Int. J. Pharm. 417 (2011) 204-215; DOI : 10.1016/j.ijpharm. 2010.10.010.
  14. 14. H. P. Deppeler, Hydrochlorothiazide, in Analitical Profiles Drug Substances, Ed. K. Florey; Academic Press. New York (1983) pp. 405- 409.
  15. 15. J. A. Mollica, C. R. Rohm, J. B. Smith and H. R. Govan, Hydrolysis of benzothiadiazines, J. Pharm. Sci. 6 (1971) 1380-1384; DOI: 10.1002/jps.2600600920.10.1002/jps.26006009205567589
  16. 16. European Pharmacopeia, 7th ed., Council of Europe, Brussels 2013.
  17. 17. S. I. F. Badaway and M. A. Hussain, Microenvironmental pH modulation in solid dosage forms, J. Pharm. Sci. 96 (2007) 948-959; DOI: 10.1002/jps.20932.10.1002/jps.2093217455349
  18. 18. K . Moodly, V. Pillay, Y. E. Choonara, L. C. du Toit, V. M. K. Ndesendo, P. Kumar, S. Cooppan and P. Bawa, Oral drug delivery systems comprising altered geometric configurations for controlled release drug delivery, Int. J. Mol. Sci. 13 (2012) 18-43; DOI : 10.3390/ijms13010018.10.3390/ijms13010018326967022312236
  19. 19. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), Guideline on the Investigation of Bioequivalence, London, 20 January 2010; http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf.
  20. 20. A . N. Elmeshad and M. K. Darwish, Stability studies of the effect of crosslinking on hydrochlorothiazide release, Drug Dis. Ther. 3 (2009) 136-142.
  21. 21. C. R. Rehm and J. B. Smith, The photometric determination of hydrochlorothiazide and its hydrolysis product, J. Am. Pharm. Assoc. Am. Pharm. Assoc. 49 (1960) 386-389.10.1002/jps.303049061713854484
  22. 22. A . Crouter and L. Briens, The effect of moisture on the flowability of pharmaceutical excipients, AAPS PharmSciTech. 15 (2014) 65-74; DOI: 10.1208/s12249-013-0036-0.10.1208/s12249-013-0036-0390915624092523
  23. 23. United States Pharmacopoeia 38, NF 33, USP Convention, Rockville 2015, pp. 3773-3774.
DOI: https://doi.org/10.1515/acph-2015-0031 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 383 - 397
Accepted on: Jul 7, 2015
Published on: Dec 17, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:

© 2015 Sandra Urek Blatnik, Rok Dreu, Stanko Srčič, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.